Kenvue Inc. logo
KVUEKenvue Inc.

Acquisitions

The latest quarterly acquisitions is $0 with a quarter-over-quarter change of 0.00%. Acquisitions represent cash spent to acquire other businesses and show externally purchased growth activity.

Acquisitions

KVUE Acquisitions

$0.00

Reported quarterly acquisitions; no daily interpolation.

-100.00% 5Y

Current Acquisitions

$0

$0

Quarter-over-Quarter Change

0.00%

vs. $0 prior quarter

Historical Data

18

Quarters of data available

Quarterly Acquisitions History

PeriodAcquisitionsQoQ Change% Change
Q1 2026$0+$0
Q4 2025$0+$0
Q3 2025$0+$0
Q2 2025$0+$0
Q1 2025$0+$0
Q4 2024$0+$0
Q3 2024$0+$0
Q2 2024$0+$0
Q1 2024$0$-7.00M-100.00%
Q4 2023$7.00M+$7.00M
Q3 2023$0+$0
Q2 2023$0+$0
Q1 2023$0+$0
Q4 2023$0+$0
Q3 2022$0$-2.00M-100.00%
Q2 2022$2.00M+$2.00M
Q1 2022$0$-90.00M-100.00%
Q4 2021$90.00M
Data as of Thursday, June 25, 2026

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ
22,000 employees
Consumer Defensive / Household & Personal Products
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk L. Perry